1 |
Bonis A, Dell'Amore A, Verzeletti V, Melan L, Zambello G, Nardocci C, Comacchio GM, Pezzuto F, Calabrese F, Rea F. Hepatoid Adenocarcinoma of the Lung: A Review of the Most Updated Literature and a Presentation of Three Cases. J Clin Med 2023;12. [PMID: 36835946 DOI: 10.3390/jcm12041411] [Reference Citation Analysis]
|
2 |
Yao Y, Guan X, Bao G, Liang J, Li T, Zhong X. Whole-exome sequencing and bioinformatics analysis of a case of non-alpha-fetoprotein-elevated lung hepatoid adenocarcinoma. Front Pharmacol 2022;13:945038. [DOI: 10.3389/fphar.2022.945038] [Reference Citation Analysis]
|
3 |
Zehra SS, Jahangir Z, Batool A. Hepatoid Adenocarcinoma of the Lung: Beyond a Shadow of Doubt and Risk of High Mortality [Letter]. OTT 2022;Volume 15:837-8. [DOI: 10.2147/ott.s380304] [Reference Citation Analysis]
|
4 |
Chen Z, Ding C, Zhang T, He Y, Jiang G. Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review. OTT 2022;Volume 15:609-27. [DOI: 10.2147/ott.s364465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|